FFC#6/2014

Development of novel methodologies for the identification of CFTR-targeted drugs: a multidisciplinary approach using Real Time Surface Plasmon Resonance interaction assay supported by bioinformatics strategies on HPC infrastructures

AREA 1 Therapies to correct the underlying defect

FFC#6/2014

Development of novel methodologies for the identification of CFTR-targeted drugs: a multidisciplinary approach using Real Time Surface Plasmon Resonance interaction assay supported by bioinformatics strategies on HPC infrastructures
€ 0 still needed
0%
€ 38.000 goal

pRINCIPAL INVESTIGATOR

Marco Rusnati (Dip. di Medicina Molecolare e Traslazionale, Università di Brescia, Unità Analisi Interazione Macromolecolare-Sez. di Oncologia Sperimentale e Immunologia)

Partner

Paola Fossa (Dip. di Farmacia, Genova) Alessandro Orro (Istituto di Tecnologie Biomediche, CNR, Segrate-Milano)

Researchers

11

Category

AREA 1 Therapies to correct the underlying defect

Duration

1 year

Goal

€ 38.000

Funds raised

€ 38.000

Objectives

To date, the development of new compounds able to correct D508-CFTR protein is based on structural studies and virtual screening of static molecular models despite, in vivo, CFTR is subject to complex conformational transitions leading to the opening of the chloride channel. Our proposal is to develop and validate 3D dynamic conformational models flanked to SPR analysis for the identification and design of new DF508 correctors. A massive library of small chemical compounds (ligands, prodrugs) will be built from the Zinc online database (http://zinc.docking.org) containing up to 21 million commercial compounds. New techniques will be applied to screen and identify lead compounds (Targeted Molecular Dynamics and GPU Accelerated Molecular Dynamics, Real time molecular interaction analysis by Surface Plasmon Resonance, SPR). The technologies optimized by our consortium will be made available for collaboration among the other research groups belonging to the Foundation.

WHO ADOPTED THE PROJECT

Delegazione FFC di Foggia

€ 8.000

Latteria Montello

€ 15.000

Delegazione FFC di Manciano Grosseto

€ 15.000

OTHER PROJECTS

Discover the other projects

GMRF#1/2026

Exploring the role of PKD1 in promoting CFTR stability and function at the cell surface

FFC#1/2026

Mapping proteins regulating CFTR mRNA stability to identify new therapeutic targets for nonsense mutations

FFC#2/2026

Evaluating the potential of phosphodiesterase inhibitors to enhance the efficacy of CFTR modulators and support personalized therapeutic approaches